Literature DB >> 36267

Pharmacokinetics of salicylate in man.

G Levy.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 36267     DOI: 10.3109/03602537909046431

Source DB:  PubMed          Journal:  Drug Metab Rev        ISSN: 0360-2532            Impact factor:   4.518


× No keyword cloud information.
  36 in total

1.  Relationships between the adverse effects of drugs and genetic polymorphism in genes encoding drug metabolizing enzymes.

Authors:  John O Miners; Richard O Day
Journal:  Br J Clin Pharmacol       Date:  2006-08-02       Impact factor: 4.335

2.  The effect of ageing on plasma albumin and plasma protein binding of diazepam, salicylic acid and digitoxin in healthy subjects and patients with renal impairment.

Authors:  A Viani; G Rizzo; M Carrai; G M Pacifici
Journal:  Br J Clin Pharmacol       Date:  1992-03       Impact factor: 4.335

Review 3.  Guide to drug dosage in renal failure.

Authors:  W M Bennett
Journal:  Clin Pharmacokinet       Date:  1988-11       Impact factor: 6.447

4.  Plasma protein binding of dipyrone metabolites in man.

Authors:  E Zylber-Katz; L Granit; M Levy
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

5.  Influence of age, sex, pregnancy and protein-calorie malnutrition on the pharmacokinetics of salicylate in rats.

Authors:  D R Varma; T L Yue
Journal:  Br J Pharmacol       Date:  1984-05       Impact factor: 8.739

6.  Aspirin use post-acute coronary syndromes: intolerance, bleeding and discontinuation.

Authors:  L Kristin Newby; Manjushri V Bhapkar; Harvey D White; David J Moliterno; Nancy M Allen LaPointe; David E Kandzari; Freek W A Verheugt; Judith M Kramer; Paul W Armstrong; Robert M Califf
Journal:  J Thromb Thrombolysis       Date:  2003-12       Impact factor: 2.300

7.  Aspirin metabolism and efficacy in postoperative dental pain.

Authors:  R A Seymour; F M Williams; A Ward; M D Rawlins
Journal:  Br J Clin Pharmacol       Date:  1984-06       Impact factor: 4.335

8.  Alleviation of mortality induced by salicylate and stress.

Authors:  P J Jastreboff; J F Brennan
Journal:  Experientia       Date:  1994-05-15

9.  Model representation of salicylate pharmacokinetics using unbound plasma salicylate concentrations and metabolite urinary excretion rates following a single oral dose.

Authors:  J Shen; S Wanwimolruk; R D Purves; E G McQueen; M S Roberts
Journal:  J Pharmacokinet Biopharm       Date:  1991-10

Review 10.  A reassessment of the treatment of salicylate poisoning.

Authors:  L Notarianni
Journal:  Drug Saf       Date:  1992 Jul-Aug       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.